as a result of the progress at both optum and unitedhealthcare, we have increased our year-six adjusted earnings outlook to a range of $num-one to $num-two per share.
our updated full-year year-six outlook includes unfavorable covid impacts, consistent with the expectations we have discussed throughout the year.
our liquidity and capital positions remain strong with third-quarter cash flows from operations at $num-one billion, or num-two times net income, and we ended the quarter with a debt-to-capital ratio of num-three%.